Fulgent Genetics Inc expected to post a loss of 33 cents a share - Earnings Preview

Fulgent Genetics

01/11/2023 18:33

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results 
    * The El Monte California-based  company is expected to
report  a
40.0% decrease in revenue to $63.407 million from $105.66
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data. The company's guidance on August 4
2023, for the period ended September 30, was for revenue of
$65.000 million.
    * ​Refinitiv's mean analyst estimate for Fulgent Genetics
Inc is
for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $36.5​, above​ its last closing price of $23.94. ​​​

This summary was machine generated November 1 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated